Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
NCT04175691 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-04-15
Summary
AISRNA is to analyze the expression pattern of circular RNA (circRNA), micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with acute ischemic stroke and healthy control. The candidate circRNA/miRNA/lncRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Conditions
- Acute Stroke
- Ischemic Stroke
Interventions
- GENETIC
-
Sequencing of circRNA/miRNA/lncRNA
Next generation sequencing of circular RNA (circRNA), micro-RNA (miRNA) and long non-coding RNA (lncRNA)
Sponsors & Collaborators
-
Nanjing First Hospital, Nanjing Medical University
lead OTHER
Principal Investigators
-
Junshan Zhou, Professor · Nanjing Medical University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-24
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
NCT03686163 ·Status: COMPLETED ·Phase: PHASE4
-
Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
NCT04590118 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).
NCT07107022 ·Status: RECRUITING
-
Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization
NCT05395351 ·Status: COMPLETED
-
"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"
NCT06656442 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis
NCT05001984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
NCT04504864 ·Status: UNKNOWN ·Phase: PHASE4
-
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
NCT07233070 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)
NCT05295173 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Normobaric Hyperoxia Stabilizing Ischemic Penumbra
NCT05781880 ·Status: UNKNOWN ·Phase: NA
-
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
NCT04676659 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of BNG-1 to Treat Acute Ischemic Stroke
NCT01675115 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
NCT04952064 ·Status: COMPLETED ·Phase: PHASE4
-
Siblings With Ischemic Stroke Study
NCT00108940 ·Status: COMPLETED
-
Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.
NCT03176498 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients
NCT05401149 ·Status: COMPLETED
-
INtravenous TNK for Acute isChemicsTroke in China
NCT04588337 ·Status: COMPLETED
-
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
NCT02059785 ·Status: SUSPENDED ·Phase: PHASE2
-
Safety and Preliminary Efficacy of NXL-001 in Patients with Ischemic Stroke
NCT06761183 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK
NCT04752631 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
NCT07084012 ·Status: RECRUITING ·Phase: PHASE2